Insmed Inc (INSM)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

700 US HIGHWAY 202/206 BRIDGEWATER, NJ 08807

Discovers and develops drug candidates for the treatment of metabolic diseases and endocrine disorders. The company's lead product candidates include recombinant human (rh) IGF-I/rhIGFBP-3, for the treatment of growth hormone insensitivity syndrome.

Data as of 2020-05-30
Market Cap2.454 Billion Shares Outstanding101.045 Million Avg 30-day Volume1.33 Million
P/E Ratio Dividend Yield EPS-2.81
Price/Sales16.209 Price cash flow ratio Price free cash flow ratio-9.1
Book Value2.91 Price to Tangible Book16.34 Alpha0.01
Short Interest Ratio % Short Interest to Float R-squared0.181399
BETA2.73469 52-week High/Low34.94 / 12.09 Stddev0.274029
View SEC Filings from INSM instead.

View recent insider trading info

Funds Holding INSM (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding INSM BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ANDERSON ELIZABETH M

  • Director
8,790 2020-05-27 1

PAULS MATTHEW

  • Director
0 2020-05-20 0

BRENNAN DAVID R

  • Director
17,537 2020-05-14 1

SCHAFER CAROL

  • Director
0 2020-05-14 3

SHAROKY MELVIN MD

  • Director
266,790 2020-05-12 1

ENGELSEN STEINAR J

  • Director
296,299 2020-05-12 1

ALTOMARI ALFRED

  • Director
40,938 2020-05-12 1

MCGIRR DAVID W J

  • Director
50,358 2020-05-12 1

LEE LEO

  • Director
31,062 2020-05-12 1

DESJARDINS CLARISSA

  • Director
13,392 2020-05-12 3

BONSTEIN SARA CHIEF FINANCIAL OFFICER

  • Officer
0 2020-05-12 3

TOMBESI PAOLO CHIEF FINANCIAL OFFICER

  • Officer
15,437 2020-03-24 0

GLOVER STEVE C

57,908 2020-02-14 0

HAYDEN DONALD J JR

0 2020-02-10 0

FMR LLC

  • 10% Owner
  • SEE REMARK 1
6,971,912 2020-02-10 0

KOLLENDER RICHARD S CHIEF OPERATING OFFICER

  • Officer
0 2020-01-27 0

POTTER MYRTLE S

  • Director
12,480 2020-01-10 0

LANFEAR DENNIS M PRESIDENT & CEO

  • Officer
  • Director
696,913 2020-01-10 0

LEWIS WILLIAM CHAIRMAN AND CEO

  • Officer
  • Director
135,092 2020-01-03 3

PELLIZZARI CHRISTINE A CHIEF LEGAL OFFICER

  • Officer
94,867 2020-01-03 1

SCHAEFFER ORLOV S NICOLE CHIEF PEOPLE STRATEGY OFFICER

  • Officer
35,552 2020-01-03 2

ADSETT ROGER CHIEF OPERATING OFFICER

  • Officer
92,721 2020-01-03 2

SORIANO JOHN CHIEF COMPLIANCE OFFICER

  • Officer
26,207 2020-01-03 1

GOLL JOHN CHIEF ACCOUNTING OFFICER

  • Officer
14,166 2020-01-03 4

FLAMMER MARTINA M.D. CHIEF MEDICAL OFFICER

  • Officer
10,526 2020-01-03 3

STRECK PAUL CHIEF MEDICAL OFFICER

  • Officer
0 2019-10-22 0

DRECHSLER ANDREW T CHIEF FINANCIAL OFFICER

  • Officer
0 2019-06-24 0

WHITCOMB RANDALL W

  • Director
0 2019-06-20 0

GUPTA RENU

  • Director
0 2017-05-25 0

SULLIVAN EUGENE JEFFREY CHIEF MED. & SCIENTIFIC OFC.

  • Officer
0 2017-05-17 0

QUIGLEY MARK VICE PRESIDENT, QUALITY

  • Officer
0 2015-05-12 0

BERRY PEGGY VICE PRESIDENT, REGULATORY

  • Officer
0 2015-02-26 0

AYER CAPITAL MANAGEMENT, LP

AYER CAPITAL PARTNERS, LLC

ACM CAPITAL PARTNERS, LLC

VENKATESAN JAY

  • Director
  • 10% Owner
5,604,015 2013-12-31 0

DRUCKER ANDREA HOLTZMAN SVP, GEN. COUNSEL & CORP SEC.

  • Officer
45,000 2013-06-03 0

WHITTEN TIMOTHY PRESIDENT & CEO

  • Officer
  • Director
10,000 2012-06-01 0

TULLY KEVIN P EXECUTIVE VP & CFO

  • Officer
0 2011-12-21 0

LABELLA NICHOLAS A. JR. CHIEF SCIENTIFIC OFFICER

  • Officer
0 2011-12-21 0

GURRERI NICHOLAS LEE SENIOR VP, COMMERCIAL OPS

  • Officer
0 2011-01-31 0

CONDON KENNETH G

  • Director
168,504 2010-06-09 0

CROOKE GRAHAM K

  • Director
228,404 2010-06-09 0

FARRAR DOUG VICE PRESIDENT, ITP

  • Officer
292,055 2009-03-31 0

ALLAN GEOFFREY PRESIDENT, CEO AND CHAIRMAN

  • Officer
  • Director
1,715,557 2009-03-31 0

KELLEY GLEN L VP, REGULATORY AFFAIRS

  • Officer
213,712 2009-03-31 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

BONSTEIN SARA - Officer CHIEF FINANCIAL OFFICER

2020-05-12 A 34,890 a 34,890 0.00 direct

SCHAFER CAROL - Director

2020-05-12 A 8,097 a 9,702 9,702.00 direct

ENGELSEN STEINAR J - Director

2020-05-12 A 8,097 a 296,299 296,299.00 direct

ANDERSON ELIZABETH M - Director

2020-05-12 A 8,097 a 20,114 20,114.00 direct

MCGIRR DAVID W J - Director

2020-05-12 A 8,097 a 50,358 50,358.00 direct

DESJARDINS CLARISSA - Director

2020-05-12 A 8,097 a 13,392 13,392.00 direct

BRENNAN DAVID R - Director

2020-05-12 A 8,097 a 63,318 63,318.00 direct

SHAROKY MELVIN MD - Director

2020-05-12 A 8,097 a 246,790 266,790.00 direct

LEE LEO - Director

2020-05-12 A 8,097 a 31,062 31,062.00 direct

ALTOMARI ALFRED - Director

2020-05-12 A 8,097 a 40,938 40,938.00 direct

Elevate your investments